Tocris Bioscience™ GLYX 13
226,87 € HT
NMDA receptor partial agonist; acts at the glycine site
- Pureté
- 0.95
- Quantité
- 1 mg
- Marque
- Tocris Bioscience
"/>
NMDA receptor partial agonist; acts at the glycine site
GLYX 13 is a NMDA receptor partial agonist that acts at the glycine site. Simultaneously acts as a promoter of the induction of long-term potentiation (LTP) and as a suppressor of long-term depression (LTD). Also promotes VGF and BDNF release and increases ERK/mTOR signaling . Exhibits nootropic, neuroprotective and antinociceptive activity, and enhances learning, memory and cognition
in vivo
. Brain penetrant.
| Marque | Tocris Bioscience |
|---|---|
| Réf. B-LABO | BL-RE-052672 |
| Réf. fabricant | 18034112 |
| Pureté | 0.95 |
| Quantité | 1 mg |